Multi-analyte Blood Test

DIAGNOSTIC_TEST3 trials

Sponsors

Helio Genomics

Conditions

COPDCancerChronic HepatitisDiabetesHCCHepatitis BHepatitis CHepatocellular Carcinoma

Unknown Phase

Clinical Trial Multi-analyte Blood Test

Active, not recruitingNCT03694600

Helio GenomicsLiver Cirrhosis

Start: 2019-02-04End: 2027-12-30Target: 1900Updated: 2026-07-10

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

RecruitingNCT05181826

Helio GenomicsCancer, Chronic Hepatitis, COPD +4

Start: 2019-05-21End: 2028-01-01Target: 1200Updated: 2026-07-10

Multi-analyte Blood Test Clinical Trial

RecruitingNCT05199259

Helio GenomicsHCC, Hepatocellular Carcinoma, Liver Cancer +1

Start: 2022-03-01End: 2028-12-01Target: 1200Updated: 2026-07-10

Related Papers

A prospective clinical trial to evaluate the performance of a multi-analyte blood test for early detection of hepatocellular carcinoma among at-risk patients with liver cirrhosis: The CLiMB study.

Journal of Clinical Oncology2023-01-241 citations